Health

American Cancer Society revises guidelines, urges routine PSA screening for prostate cancer

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 12/11/2026, 12:06:24 UTC.

Briefings

The American Cancer Society updated its prostate cancer screening guidelines, recommending biennial PSA testing for men aged 50 to 69 at average risk. This marks a shift from the 2010 guidelines which left decisions to physicians. The new recommendation applies to men in the specified age range with average risk, though the source does not specify the exact number of men affected or the specific impact on cancer detection rates.

Key points

• The American Cancer Society recommends biennial PSA testing for men aged 50 to 69 at average risk.
• The prior 2010 guidelines left testing for average-risk men to their discretion after assessing cancer risk with a physician.

Context

The American Cancer Society is revising its prostate cancer screening guidelines, which previously left testing for average-risk men to their discretion after assessing cancer risk with a physician. This update applies to men aged 50 to 69 at average risk.

Limitations

The source provides no data on the number of men affected by the change, the specific impact on cancer detection rates, or the exact number of men affected by the change. The source does not specify the exact number of men affected by the change.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 12/11/2026, 13:04:58 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeidk75nqg3tkt3pw4cq6yhtdtubj4b2cijujqytsmoo4t66irz4ft4